Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Choriogonadotropin alfa 250micrograms injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Product containing choriogonadotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
choriogonadotropin alfa 250 µg pulver til injektionsvæske, rekonstitution + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
choriogonadotropin alfa 1500 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
choriogonadotropin alfa 2000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
choriogonadotropin alfa 5000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
choriogonadotropin alfa 10.000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
choriogonadotropin alfa 250 µg injektionsvæske, opløsning, 0,5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
|
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing choriogonadotropin alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing only choriogonadotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Choriogonadotropin alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Some |
1 |